Loading data
PCARNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 28.44 bn USD | 33.66 bn USD | 35.13 bn USD | 28.82 bn USD | 23.52 bn USD |
| Cost of revenue | 22.74 bn USD | 26.07 bn USD | 26.89 bn USD | 23.29 bn USD | — |
| Research and development expense | 445.5 m USD | 452.9 m USD | 410.9 m USD | 341.2 m USD | — |
| Selling, general and administrative expense | 735.8 m USD | 744 m USD | 753.3 m USD | 726.3 m USD | — |
| Profit before tax | 3.02 bn USD | 5.4 bn USD | 5.72 bn USD | 3.85 bn USD | 2.4 bn USD |
| Income tax expense | 647.7 m USD | 1.24 bn USD | 1.12 bn USD | 837.1 m USD | 530.8 m USD |
| Net income (reported basis) | 2.4 bn USD | 4.2 bn USD | 4.6 bn USD | 3 bn USD | 1.9 bn USD |
| Basic earnings per share | 4.52 USD/share | 7.92 USD/share | 8.78 USD/share | 5.76 USD/share | 3.58 USD/share |
| Diluted earnings per share | 4.51 USD/share | 7.9 USD/share | 8.76 USD/share | 5.75 USD/share | 3.57 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.